Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
allergy
Biotech
Regeneron antibodies post ph. 3 wins against cat, pollen allergy
Regeneron’s allergen-blocking antibodies have reduced the symptoms of cat and pollen allergies in a pair of phase 3 studies.
James Waldron
Sep 8, 2025 9:54am
Rapt Tx cuts staff for 2nd time in less than a year
Jun 4, 2025 4:46pm
Jasper eyes next indication for hive drug, thanks to mouse data
Feb 26, 2024 6:00am
Could antihistamines boost I-O treatments?
Nov 29, 2021 9:35am
J&J's allergy-fighting contact lens nets first approval in Japan
Mar 24, 2021 10:18am
DBV preps 200 layoffs after nasty FDA reaction to peanut patch
Jan 7, 2021 11:18am